Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38357
CAS Number:
163521-08-2
Clorhidrato de vilazodona
Purity:
≥ 98 % (HPLC)
Synonym(s):
Clorhidrato de 5-[4-[4-(5-ciano-1 H -indol-3-il)butil]piperazin-1-il]benzofuran-2-carboxamida
Documents
$263.29 /50 mg
Tamaño
Request Bulk Quote
Product Information

Conservar bajo gas inerte.

Synonyms
Clorhidrato de 5-[4-[4-(5-ciano-1 H -indol-3-il)butil]piperazin-1-il]benzofuran-2-carboxamida
CAS Number
163521-08-2
Purity
≥ 98 % (HPLC)
Molecular Formula
C26H27N5O2 · HCl
Molecular Weight
477.99
MDL Number
MFCD00940014
PubChem ID
6918313
Melting Point
279 °C
Appearance
Polvo de color blanco a amarillo claro hasta cristal.
Conditions
Conservar a < -20 °C
General Information
Synonyms
Clorhidrato de 5-[4-[4-(5-ciano-1 H -indol-3-il)butil]piperazin-1-il]benzofuran-2-carboxamida
CAS Number
163521-08-2
Purity
≥ 98 % (HPLC)
Molecular Formula
C26H27N5O2 · HCl
Molecular Weight
477.99
MDL Number
MFCD00940014
PubChem ID
6918313
Melting Point
279 °C
Appearance
Polvo de color blanco a amarillo claro hasta cristal.
Conditions
Conservar a < -20 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Vilazodone hydrochloride is widely utilized in research focused on:

  • Treatment of Depression: This compound is primarily used as an antidepressant, helping to alleviate symptoms of major depressive disorder by acting on serotonin receptors, providing a dual mechanism of action that can be more effective than traditional SSRIs.
  • Psychiatric Research: Researchers explore its effects on mood and anxiety disorders, contributing to a better understanding of mental health treatments and the biochemical pathways involved.
  • Pharmaceutical Development: Vilazodone is a key compound in the development of new medications, allowing pharmaceutical companies to innovate and improve therapeutic options for patients with depression.
  • Clinical Trials: It is frequently used in clinical studies to assess efficacy and safety, providing valuable data that helps refine treatment protocols and patient care strategies.
  • Combination Therapies: The compound is also investigated for use in combination with other medications to enhance therapeutic outcomes, particularly in patients who do not respond to standard treatments.

Citas